Page 1910 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

Index 1337

Detoxification, 1203–1206 Diving medicine, 1317–1323 in diagnosing mitral regurgitation, 351
activated charcoal, 1203–1204 with compressed gases, 1319–1321, 1320f in diagnosing right heart syndromes,
extracorporeal removal of toxins, immersion and breath-hold diving, 311–312
1205–1206 1318–1319, 1319f in diagnosing tricuspid regurgitation, 352
forced diuresis and urinary manipulations, physics of underwater environments, in diagnosing valvular diseases, 345
1204–1205, 1204t 1318, 1318t in evaluating constrictive pericarditis,
gastric emptying, 1203 therapy of decompression illness, 341–342, 342f
whole-bowel irrigation, 1204 1322–1323, 1323f Eclampsia, 927
Devic disease, 676 venous and arterial gas embolism, Economic evaluations in health care, 38
Device-related infections, 598–599, 598t 1321–1322 Eczema herpeticum, 1300, 1301f
Dexmedetomidine, 153–154 Dobrava-Belgrade virus, 742 Edema
for delirium, 763 Dobutamine, 331, 573 cerebral, 774, 976
D+ hemolytic-uremic syndrome (D+ HUS), “Do no harm,” 3 mass effect and, 794–795, 794t, 795f
diagnosis of, 861 Donor, evaluation of potential, 1110–1113 cytotoxic, 794
Diabetes insipidus, managing, 840 Do-Not-Resuscitate (DNR) order, 128 high-pressure pulmonary, 384
Diabetes mellitus in high-risk surgical Dopamine in acute renal failure, 930–931, 930t hydrocephalic, 794
patients, 1058–1059 Doppler US, 222 hydrostatic, 794
Diabetic ketoacidosis (DKA), 974 Doripenem, 546 interstitial, 794
Diagnostic and Statistical Manual of Mental Dose-dependent effects, 1227 ischemic, 794
Disorders (DSM-IV), 756 Drainage system, chest tube management and, osmotic, 794
Diagnostic errors, reducing, 34–36 508–509 pulmonary, 239–240, 240f
Diagnostic peritoneal lavage (DPL), 1161 DRESS syndrome, 1290 diagnosis and management of, 200–201
Diagnostic tests, understanding, 47–48 Droplet precautions in intensive-care vasogenic, 794
Diaphoresis, 498 unit, 29–30 corticosteroids for, 812–813
Diaphragmatic rupture, 1160 Drowning, 1323–1326 Edema bullae, 1295–1296, 1296f
Diarrhea, 705–708, 706t, 1001–1004 definition, 1323 Elderly patient with elevated sedimentation
Clostridium difficile in, hypothermia, 1326 rate, 1246
1003–1004, 1004f management, 1324–1325, 1325f Electrical trauma, 1175–1180, 1176t, 1177t
evaluation of critically ill patient with, neurological considerations, cardiac, 1177
706t, 707–708 1325–1326, 1325t extremity and wound, 1178–1179
hemorrhagic, 707 pathophysiology, 1323–1324 gastrointestinal, 1178
inflammatory, 706–707 prognosis, 1326 initial evaluation, 1176–1177
management of, in critical care, Drug administration, route of, 1228 late sequelae of injury, 1179–1180
1001–1003 Drug distribution and elimination, lightning injury, 1179
noninflammatory, 706 1224–1226, 1224f, 1225ft, 1226 neurologic, 1178
treatment of, 708, 708t Drug dosing, obesity and, 1310 pulmonary, 1178
Diastolic dysfunction, 256, 257t, 258f Drug-drug interactions, 628 renal, 1177–1178
management of, 274 consideration of potential, 1238–1239 Electric shock, 1176
Diastolic stiffness, increased, 274 Drug fever, 560 Electrocardiography, 295
Diastolic V-P curve, in ventricular filling Drug-induced anaphylaxis, 1283 in diagnosing mitral stenosis, 349
disorders, 231, 231ft Drug-induced thrombocytopenia, in diagnosing right heart syndromes, 311
Diazepam, 152 850–851, 850t, 851t Electrolyte disorders in critical care, 943–968
Dieulafoy lesion, 1017 Drugs/definitive therapy, 253 calcium, 957–962
Diffuse alveolar hemorrhage, 887 Duchenne muscular dystrophy (DMD), 1062 hypercalcemia, 960–962, 961t, 962t
Diffuse axonal injury (DAI), 1123 Ductal injury, 1163 hypocalcemia, 957–960, 958t, 959t, 960t
Diffuse brain disease (dementia and Duodenal injuries, 1162–1163, 1162f metabolism, 957, 957f, 958f
encephalopathy), 640 Dysfunction, effects of circulatory, 1237 magnesium, 965–968
Diffuse reversible edema syndrome Dysglycemia, 977 hypermagnesemia, 967–968
(DRES), 819 Dyspnea, 405 hypomagnesemia, 966–967, 966t
Diffusion of responsibility, 67 Dysregulated inflammation, 454 metabolism, 965–966
Digital imaging and communications in phosphorus, 962–965
medicine (DICOM), 54 E hyperphosphatemia, 964–965, 965t
Digoxin, 1216–1217, 1216t Early afterdepolarization, 278 hypophosphatemia, 962–964, 963t, 964t
Dilutional thrombocytopenia, 850 Early Goal-Directed Therapy algorithm, metabolism, 962
Dipyridamole, 316 251, 252f renal handling of, 962
Direct thrombin inhibitors, 304, 328–329 Early mobilization, 164–165 potassium, 950–957
Disaster response, organizing hospital Early total care, damage control orthopaedic hypokalemia, 951–954, 951t, 953f
for, 60, 60ft treatment versus, 1175 metabolism, 950–951, 950f
Discounting, 42 Eastern equine encephalitis virus (EEEV), 673 sodium, 944–950
Discovery in critical care, 5–7, 5t Eaton-Lambert syndrome, 826 hypernatremia, 945–947, 946ft, 947f
Discrimination, 84–85 Ebola hemorrhagic fever, 740 hyponatremia, 947–950, 947f, 948ft
Disseminated candidiasis, 1303 Ebola/Marburg, 718 metabolism, 944–945, 944t
Disseminated intravascular coagulation Echinocandins, 650 Electronic health record (EHR), 55
(DIC), 855, 855t, 870–871 Echocardiography, 266–268, 296 adoption of, 129
Diuretics in acute renal failure, 929–930 in advanced critical care, 207–208 health information technology and, 49
Diverticular bleeding, 1018 in diagnosing aortic regurgitation, 347–348 impact of, 50, 51t

Index.indd 1337 23-01-2015 15:33:51